UK dividends calendar - next 7 days
1st Oct 2026 12:05
(Alliance News) - Stock prices in London were higher at midday on Tuesday, as pharmaceutical stocks advanced and investors digested UK mortgage data showing approvals at their lowest level since the end of 2023. Read More
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More
(Alliance News) - Stock prices in London opened higher on Tuesday, as pharmaceutical and mining stocks advanced, while oil prices eased amid signs of progress towards renewed talks between the US and Iran. Read More
Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Initiates the phase Ia portion, or initial dose-finding stage, of a global clinical trial of HMPL-A830 in patients with advanced or metastatic solid tumours. Says the first patient received an initial dose in China on September 24. The phase I study will assess safety, tolerability, pharmacokinetics, immunogenicity and preliminary efficacy, with the initial dose-escalation stage intended to determine the maximum tolerated dose and recommended dose for expansion. Hutchmed says the antibody-targeted therapy combines a KRAS inhibitor with an anti-EGFR antibody to target KRAS-altered, EGFR-expressing tumours. The company is responsible for global phase I development under an agreement with GSK, which holds worldwide rights outside mainland China, Hong Kong, Macau and Taiwan. Read More
(Alliance News) - Land Securities agrees to sell a London office for GBP211 million, while Entain maintains its annual guidance despite an online betting ban in Brazil. HICL Infrastructure invests around GBP68 million in Scandinavian rail freight operator Hector Rail. Read More
(Alliance News) - Stocks in London made modest progress on Friday as lower oil prices amid hopes of progress in US-Iran negotiations helped offset concerns over another rise in bond yields. Read More
Hikma Pharmaceuticals PLC - London-based pharmaceutical maker - Appoints Rebecca Hall as chief financial officer, effective from a to-be-announced date in the first quarter of 2027, which Hikma will confirm "in due course." Hall joins Hikma from ViiV Healthcare Ltd, a specialist HIV pharmaceutical company majority owned by GSK PLC, with pharma firm Shionogi & Co Ltd as a shareholder. At ViiV Healthcare, Hall is senior vice president and CFO, responsible for finance, supply chain and business development. Hikma Chair Victoria Hull said: "Becky's appointment is a further step in broadening the expertise we have across both the executive team and the board, positioning us well for long-term sustainable growth." Read More
(Alliance News) - Vault Ventures PLC on Monday announced a change of name and leadership as it moves towards bringing its first product to the market. Read More
(Alliance News) - UK inflation accelerates to 3.1% in August as higher fuel costs drive prices higher. Barratt Redrow reports a rise in annual pretax profit but lowers its home completions guidance, while Babcock says trading is in line with expectations and leaves its outlook unchanged. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
(Alliance News) - GSK PLC on Tuesday said it has agreed to buy "a potential best-in-class" T cell-engager aimed at treating multiple myeloma from China-based clinical-stage biotechnology company Chimagen Biosciences for up to USD750 million. Read More
(Alliance News) - GSK says it has struck a deal to acquire a promising T-cell asset, while Kier Group's annual profit beat consensus. Read More
(Alliance News) - Stock prices in London closed mixed on Monday, with Middle East tensions, AI slowdown fears and caution ahead of a flurry of central bank meetings keeping investors on their toes. Read More
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More
(Alliance News) - GSK PLC on Monday reported positive findings from a phase I/II trial evaluating zidesamtinib in patients with non-small cell lung cancer who have not received previous treatment. Read More
(Alliance News) - GSK PLC on Thursday said its Shingrix shingles vaccine has been approved by Japan's Ministry of Health, Labour & Welfare. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
(Alliance News) - Stock prices in London closed lower on Tuesday, as Bank of England Governor Andrew Bailey warned of upside inflation risks amid elevated energy prices, while Computacenter reversed an early rally to finish at the bottom of the FTSE 100. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More